Literature DB >> 2468653

Monoclonal antibodies recognizing different epitopes of the 27-kDa gap junction protein from rat liver.

A Takeda1, M Kanoh, T Shimazu, N Takeuchi.   

Abstract

Monoclonal antibodies (2-3E2, 6-3G11, and 7-3H6) against gap junction plaques purified from rat liver were prepared and characterized. Immunoblot analysis of liver gap junctions revealed that all three antibodies reacted with the 27-kDa protein, but not with the 22-kDa one. The 2-3E2 and 6-3G11 antibodies both reacted with the 27-kDa protein in gap junctions purified from livers of the rat, mouse, rabbit, and guinea pig; the 7-3H6 antibody, however, failed to react with the 27-kDa protein from guinea pig liver. The 7-3H6 antibody reacted strongly with the 24- to 26-kDa degradation products of the 27-kDa protein. Indirect immunofluorescence showed that the 6-3G11 and 7-3H6 antibodies both gave the same specific fluorescence labeling on rat liver cryosections, suggesting that these two antibodies recognized the cytoplasmic sites of the 27-kDa protein. Immunoblot analysis of protease-digested fragments from the 27-kDa protein revealed that the 7-3H6 antibody reacted with the 24- and 17-kDa fragments (including portions of the carboxyl-terminal domain of the 27-kDa protein) produced with endoproteinases Arg-C and Lys-C, respectively. Immunoblot analysis of CNBr fragments of the 27-kDa protein revealed that all three antibodies reacted with the 10-kDa fragment, which is thought to be the carboxyl-terminal domain of the 27-kDa protein. These results demonstrate that three monoclonal antibodies recognize different epitopes of the cytoplasmic sites (probably the carboxyl-terminal domain) of the 27-kDa liver gap junction protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2468653     DOI: 10.1093/oxfordjournals.jbchem.a122580

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  Immunocytochemical studies of major gap junction proteins in rat salivary glands.

Authors:  A Kuraoka; I Yamanaka; A Miyahara; Y Shibata; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

2.  Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.

Authors:  Y Omori; M Mesnil; H Yamasaki
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

3.  Reduction of gap junction protein connexin 32 in rat atrophic gastric mucosa as an early event in carcinogenesis.

Authors:  A Nagahara; S Watanabe; H Miwa; K Endo; M Hirose; N Sato
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

4.  Expression of connexin 32 gap junction protein in the kidneys during fetal development of the hamster (Mesocricetus auratus).

Authors:  N Udaka; T Ito; Y Sato; S Satoh; M Kanisawa
Journal:  Anat Embryol (Berl)       Date:  1995-11

5.  Morphological alterations of gap junctions in phalloidin-treated rat livers.

Authors:  M Ohta; T Okanoue; S Takami; Y Nagao; T Mori; N Hori; M Oka; K Kagawa; K Kashima
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

6.  Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats.

Authors:  H Sakamoto; M Oyamada; K Enomoto; M Mori
Journal:  Jpn J Cancer Res       Date:  1992-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.